Corrections & Clarifications: “Wolf Man” director and co-writer Leigh Whannell's name was incorrect in an earlier version of this article. Pity the werewolf. I mean, duh. You get bitten or ...

Wedbush reissued their outperform rating on shares of Werewolf Therapeutics (NASDAQ:HOWL – Free Report) in a report issued on Wednesday morning, Marketbeat Ratings reports. They currently have a ...

Bank of America Securities analyst Jason Zemansky reiterated a Buy rating on Werewolf Therapeutics (HOWL – Research Report) today and set a price target of $10.00. The company’s shares closed ...